JavaScript is disabled for your browser. Some features of this site may not work without it.
Please be advised that the site will be down for maintenance on Sunday, September 1, 2024, from 08:00 to 18:00, and again on Monday, September 2, 2024, from 08:00 to 09:00. We apologize for any inconvenience this may cause.
Strain 19 Brucella vaccine. II. The preparation of freeze-dried live vaccine
Van Drimmelen, G.C.; Alexander, R.A.; Clark, R.; Louw, J.G.; De Kock, V.E.
A freeze-dried Brucella vaccine has been developed which can be issued with all the usual guarantees, e.g. 60 x 10⁹ viable organisms per dose viable for an extended period. This vaccine has been prepared in concentrated form which makes it possible to reconstitute the contents of one ampoule into a number of doses. Such a vaccine is eminently suitable for use in Southern Africa especially in the more remote areas. Concentration by means of carboxy-methyl-cellulose of the organisms grown in aerated liquid culture increased the dosage per ampoule and the survival rate after freeze-drying and during storage.
Description:
The articles have been scanned in colour with a HP Scanjet 5590; 300dpi.
Adobe Acrobat XI Pro was used to OCR the text and also for the merging and conversion to the final presentation PDF-format.